<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1682">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05139264</url>
  </required_header>
  <id_info>
    <org_study_id>AAAT6779</org_study_id>
    <nct_id>NCT05139264</nct_id>
  </id_info>
  <brief_title>Glucose, Activity, Diet, &amp; Sleep Assessment Study</brief_title>
  <acronym>GLADS</acronym>
  <official_title>GLADS Study: Glucose, Activity, Diet, &amp; Sleep Assessment Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      GLADS is a cross-sectional, observational study assessing free-living diet, physical&#xD;
      activity, sleep, and glucose profile over a 2-week period in healthy adult men and women.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Monitoring free-living lifestyle behaviors can provide important information on behavioral&#xD;
      determinants of health. New technologies have improved accessibility of ambulatory assessment&#xD;
      of diet, biomarkers, physical activity, and sleep. The study will assess the effects of&#xD;
      free-living diet assessed by questionnaire and sleep and physical activity measured by&#xD;
      actigraphy on interstitial glucose measured by continuous glucose monitoring in healthy adult&#xD;
      men and women over a 2-week period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 3, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose</measure>
    <time_frame>2 weeks</time_frame>
    <description>Mean, fasting, post-prandial measured by continuous glucose monitoring</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep duration</measure>
    <time_frame>2 weeks</time_frame>
    <description>Measured by actigraphy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep fragmentation</measure>
    <time_frame>2 weeks</time_frame>
    <description>Measured by actigraphy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diet composition</measure>
    <time_frame>2 weeks</time_frame>
    <description>Carbohydrates, fats, proteins assessed by dietary recall</description>
  </secondary_outcome>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Metabolism Disorder, Glucose</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
    <description>Observation of diet, physical activity, sleep and interstitial glucose</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult men and women willing to record food intake with their smartphone, complete online&#xD;
        questionnaires, and wear body sensors to measure physical activity, sleep, and glucose.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: 18-75 y old&#xD;
&#xD;
          -  In possession of a smartphone&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
          -  Live in New York City metro area&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active food intake disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Blandine Laferrere, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Delaney Shaw, MS</last_name>
    <phone>212-851-5576</phone>
    <email>ds3936@cumc.columbia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Blandine Laferrere, MD, PhD</last_name>
    <phone>212-851-5562</phone>
    <email>bbl14@cumc.columbia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Russ Berrie Medical Science Pavilion</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delaney Shaw, MS</last_name>
      <phone>212-851-5576</phone>
      <email>ds3936@cumc.columbia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Blandine Laferrere, MD, PhD</last_name>
      <phone>212-851-5562</phone>
      <email>bbl14@cumc.co</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 18, 2021</study_first_submitted>
  <study_first_submitted_qc>November 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 1, 2021</study_first_posted>
  <last_update_submitted>November 30, 2021</last_update_submitted>
  <last_update_submitted_qc>November 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Blandine Laferrere</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Glucose Metabolism Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

